LOW AFFINITY BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES AND USES THEREFOR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120171120A1
SERIAL NO

13306524

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies that bind blood brain barrier receptors (BBB-R) and methods of using the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
F. HOFFMANN-LA ROCHE AGNUTLEY, NJ228

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dennis, Mark South San Francisco, US 41 122
Watts, Ryan Jefferson South San Francisco, US 5 4
Yu, Yunhua Joy San Francisco, US 2 4
Zhang, Yin South San Francisco, US 68 368

Cited Art Landscape

Patent Info (Count) # Cites Year
 
UNIVERSITY OF ROCHESTER (1)
* 5231000 Antibodies to A4 amyloid peptide 141 1991
 
2-BBB MEDICINES B.V. (1)
* 2008/0213,179 Differentially Expressed Nucleic Acids in the Blood-Brain Barrier Under Inflammatory Conditions 1 2004
 
WISCONSIN ALUMNI RESEARCH FOUNDATION (1)
* 2008/0019,984 BLOOD-BRAIN BARRIER TARGETING ANTIBODIES 3 2007
 
VIB VZW (1)
* 2012/0237,526 BACE1 INHIBITORY ANTIBODIES 3 2010
 
ABBVIE INC. (1)
* 2011/0044,980 Dual Variable Domain Immunoglobulins and Uses Thereof 27 2010
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
F. HOFFMANN-LA ROCHE AG (1)
8772457 BACE1 antibodies 0 2011
 
THE JOHNS HOPKINS UNIVERSITY (2)
9579374 Method for rapidly designing pharmaceutical preparations for preventing viral infection 0 2014
9696295 Method for rapidly designing pharmaceutical preparations for preventing viral infection 0 2017
 
Genentech, Inc. (1)
9453079 Methods and compositions for neural disease immunotherapy 0 2014
* Cited By Examiner